pubmed-article:15794547 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15794547 | lifeskim:mentions | umls-concept:C0031268 | lld:lifeskim |
pubmed-article:15794547 | lifeskim:mentions | umls-concept:C1335703 | lld:lifeskim |
pubmed-article:15794547 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
pubmed-article:15794547 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
pubmed-article:15794547 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:15794547 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
pubmed-article:15794547 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:15794547 | pubmed:dateCreated | 2005-3-29 | lld:pubmed |
pubmed-article:15794547 | pubmed:abstractText | We performed a retrospective study of 47 patients to ascertain the ability of combined positron-emission tomography and computed tomography (PET/CT) to localize recurrent head and neck cancer. When clinically warranted, biopsies were performed in an attempt to obtain pathologic confirmation of the PET/CT findings. Of the 47 patients, 33 exhibited PET/CT findings consistent with recurrent cancer. Of the 33 patients, 25 underwent either biopsy or surgical excision of disease in an attempt to obtain a pathologic confirmation. Biopsy analysis confirmed the PET/CT findings in 22 of these patients; in the remaining 3 patients, pathologic findings were inconsistent with the PET/CT diagnosis. Based on the subset of 25 patients who underwent pathologic testing, the sensitivity of combined PET/CT was 95% and the specificity was 60%. We conclude that combined PET/CT imaging is a valuable tool for localizing tumor recurrence in patients with head and neck cancer. | lld:pubmed |
pubmed-article:15794547 | pubmed:language | eng | lld:pubmed |
pubmed-article:15794547 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15794547 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15794547 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15794547 | pubmed:month | Feb | lld:pubmed |
pubmed-article:15794547 | pubmed:issn | 0145-5613 | lld:pubmed |
pubmed-article:15794547 | pubmed:author | pubmed-author:TownsendDavid... | lld:pubmed |
pubmed-article:15794547 | pubmed:author | pubmed-author:MeltzerCaroly... | lld:pubmed |
pubmed-article:15794547 | pubmed:author | pubmed-author:FukuiMelanie... | lld:pubmed |
pubmed-article:15794547 | pubmed:author | pubmed-author:SnydermanCarl... | lld:pubmed |
pubmed-article:15794547 | pubmed:author | pubmed-author:BlodgettToddT | lld:pubmed |
pubmed-article:15794547 | pubmed:author | pubmed-author:ZimmerLee ALA | lld:pubmed |
pubmed-article:15794547 | pubmed:author | pubmed-author:McCookBarryB | lld:pubmed |
pubmed-article:15794547 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15794547 | pubmed:volume | 84 | lld:pubmed |
pubmed-article:15794547 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15794547 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15794547 | pubmed:pagination | 104, 106, 108-10 | lld:pubmed |
pubmed-article:15794547 | pubmed:meshHeading | pubmed-meshheading:15794547... | lld:pubmed |
pubmed-article:15794547 | pubmed:meshHeading | pubmed-meshheading:15794547... | lld:pubmed |
pubmed-article:15794547 | pubmed:meshHeading | pubmed-meshheading:15794547... | lld:pubmed |
pubmed-article:15794547 | pubmed:meshHeading | pubmed-meshheading:15794547... | lld:pubmed |
pubmed-article:15794547 | pubmed:meshHeading | pubmed-meshheading:15794547... | lld:pubmed |
pubmed-article:15794547 | pubmed:meshHeading | pubmed-meshheading:15794547... | lld:pubmed |
pubmed-article:15794547 | pubmed:meshHeading | pubmed-meshheading:15794547... | lld:pubmed |
pubmed-article:15794547 | pubmed:meshHeading | pubmed-meshheading:15794547... | lld:pubmed |
pubmed-article:15794547 | pubmed:meshHeading | pubmed-meshheading:15794547... | lld:pubmed |
pubmed-article:15794547 | pubmed:meshHeading | pubmed-meshheading:15794547... | lld:pubmed |
pubmed-article:15794547 | pubmed:meshHeading | pubmed-meshheading:15794547... | lld:pubmed |
pubmed-article:15794547 | pubmed:meshHeading | pubmed-meshheading:15794547... | lld:pubmed |
pubmed-article:15794547 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15794547 | pubmed:articleTitle | The use of combined PET/CT for localizing recurrent head and neck cancer: the Pittsburgh experience. | lld:pubmed |
pubmed-article:15794547 | pubmed:affiliation | Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh Medical Center, PA 15213-2546, USA. ZimmerL@upmc.edu | lld:pubmed |
pubmed-article:15794547 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15794547 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15794547 | lld:pubmed |